| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ahmed Aboraya, Jennifer Schumacher, Ehab Abdalla, James LePage, Melanie McGhee, Deborah Butcher, Holly Griffin, Mohammed Shahd. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. The West Virginia medical journal. vol 98. issue 2. 2002-07-03. PMID:12048741. |
he was diagnosed with schizophrenia and treated with eight days of risperidone followed by five days of olanzapine. |
2002-07-03 |
2023-08-12 |
Not clear |
| Xiang Yang Zhang, Dong Feng Zhou, Cao Lian Yuan, Pei Yan Zhang, Gui Ying Wu, Yu Cun She. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Psychiatry research. vol 109. issue 3. 2002-06-28. PMID:11959366. |
in this study, 30 male inpatients with a diagnosis of chronic schizophrenia (dsm-iii-r) were assigned to 12 weeks of treatment with risperidone after a 2-week washout period. |
2002-06-28 |
2023-08-12 |
human |
| Veena Kumari, William Soni, Tonmoy Sharm. Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophrenia research. vol 55. issue 1-2. 2002-06-25. PMID:11955973. |
further longitudinal within-subject studies are now required to examine whether risperidone is superior to typical antipsychotics in improving information processing functions, as assessed by ppi of the acoustic startle response, in treatment-responsive male patients with schizophrenia. |
2002-06-25 |
2023-08-12 |
human |
| Robert M Bilder, Robert S Goldman, Jan Volavka, Pal Czobor, Matthew Hoptman, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph McEvoy, Michal Kunz, Miranda Chakos, Thomas B Cooper, Terri L Horowitz, Jeffrey A Lieberma. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. The American journal of psychiatry. vol 159. issue 6. 2002-06-21. PMID:12042192. |
neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. |
2002-06-21 |
2023-08-12 |
Not clear |
| Norbert Müller, Michael Riedel, Constanze Scheppach, Bernd Brandstätter, Safet Sokullu, Karin Krampe, Markus Ulmschneider, Rolf R Engel, Hans-Jürgen Möller, Markus J Schwar. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. The American journal of psychiatry. vol 159. issue 6. 2002-06-21. PMID:12042193. |
beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. |
2002-06-21 |
2023-08-12 |
Not clear |
| Hidehisa Yamashita, Shigeru Morinobu, Shigeto Yamawaki, Jun Horiguchi, Masatsugu Naga. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry research. vol 109. issue 2. 2002-06-19. PMID:11927138. |
effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. |
2002-06-19 |
2023-08-12 |
Not clear |
| Hidehisa Yamashita, Shigeru Morinobu, Shigeto Yamawaki, Jun Horiguchi, Masatsugu Naga. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry research. vol 109. issue 2. 2002-06-19. PMID:11927138. |
the aim of the present study is to determine the effect of the atypical antipsychotic drug, risperidone on sleep measures in patients with schizophrenia by polysomnography. |
2002-06-19 |
2023-08-12 |
Not clear |
| Y Kaned. Effects of risperidone on gonadal axis hormones in schizophrenia. The Annals of pharmacotherapy. vol 35. issue 12. 2002-06-11. PMID:11793612. |
effects of risperidone on gonadal axis hormones in schizophrenia. |
2002-06-11 |
2023-08-12 |
Not clear |
| Kwang-Soo Kim, Chi-Un Pae, Jeong-Ho Chae, Won-Myong Bahk, Tae-Youn Jun, Dai-Jin Kim, Ruth A Dickso. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. The Journal of clinical psychiatry. vol 63. issue 5. 2002-06-06. PMID:12019665. |
effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. |
2002-06-06 |
2023-08-12 |
Not clear |
| Kwang-Soo Kim, Chi-Un Pae, Jeong-Ho Chae, Won-Myong Bahk, Tae-Youn Jun, Dai-Jin Kim, Ruth A Dickso. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. The Journal of clinical psychiatry. vol 63. issue 5. 2002-06-06. PMID:12019665. |
this study was conducted to prospectively examine the effect of switching from risperidone to olanzapine on female schizophrenia patients who experienced menstrual disturbances, galactorrhea, and/or sexual dysfunction. |
2002-06-06 |
2023-08-12 |
Not clear |
| K Zavitsanou, X F Huan. Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study. Neuroscience. vol 109. issue 4. 2002-05-23. PMID:11927153. |
competition experiments were performed in order to examine the pharmacological profile of [(3)h]spiperone binding, and revealed that: (i) displacement of [(3)h]spiperone binding by clozapine and mianserin was significantly reduced in the schizophrenia group as compared to the control group (-26% and -16% respectively); (ii) the order of displacement potency of the drugs tested was: haloperidol>mianserin>butaclamol approximately risperidone>clozapine>2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene. |
2002-05-23 |
2023-08-12 |
Not clear |
| Joseph I Friedman, David N Adler, Evelyn Howanitz, Philip D Harvey, Grant Brenner, Humberto Temporini, Leonard White, Michael Parrella, Kenneth L Davi. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biological psychiatry. vol 51. issue 5. 2002-05-13. PMID:11904128. |
a double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. |
2002-05-13 |
2023-08-12 |
Not clear |
| Yoram Barak, Eyal Shamir, Ronit Weizma. Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. Journal of clinical psychopharmacology. vol 22. issue 2. 2002-05-13. PMID:11910255. |
fifty-one patients, mean age 72.7 + 5.9 years, mean disease duration 33.1 + 12.0 years, who met the dsm-iv criteria for schizophrenia or schizoaffective disorder were treated by risperidone (n = 26) or typical antipsychotic treatment (n = 25) during acute exacerbation and followed up for 18 months. |
2002-05-13 |
2023-08-12 |
Not clear |
| Monique P Curran, Caroline M Perr. Spotlight on amisulpride in schizophrenia. CNS drugs. vol 16. issue 3. 2002-05-03. PMID:11888341. |
in comparative trials, amisulpride administered within this range (400 to 1200 mg/day) was as effective as haloperidol 5 to 40 mg/day, flupenthixol 25 mg/day and risperidone 8 mg/day in patients with acute exacerbations of schizophrenia with predominantly positive symptoms. |
2002-05-03 |
2023-08-12 |
Not clear |
| S B Hutto. Improved antisaccade performance in schizophrenia with risperidone. Journal of neurology, neurosurgery, and psychiatry. vol 72. issue 4. 2002-05-01. PMID:11909895. |
improved antisaccade performance in schizophrenia with risperidone. |
2002-05-01 |
2023-08-12 |
Not clear |
| J G Burke, M A Revele. Improved antisaccade performance with risperidone in schizophrenia. Journal of neurology, neurosurgery, and psychiatry. vol 72. issue 4. 2002-05-01. PMID:11909901. |
improved antisaccade performance with risperidone in schizophrenia. |
2002-05-01 |
2023-08-12 |
Not clear |
| Zhongyun Zha. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. Managed care interface. vol 15. issue 2. 2002-04-24. PMID:11875967. |
a retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. |
2002-04-24 |
2023-08-12 |
Not clear |
| Zhongyun Zha. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. Managed care interface. vol 15. issue 2. 2002-04-24. PMID:11875967. |
this retrospective study evaluates drug treatment patterns and economic outcomes of olanzapine in comparison with risperidone in the treatment of schizophrenia in usual practice. |
2002-04-24 |
2023-08-12 |
Not clear |
| Zhongyun Zha. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. Managed care interface. vol 15. issue 2. 2002-04-24. PMID:11875967. |
the results of this study suggest that the initial selection of an antipsychotic for the treatment of schizophrenia is important: olanzapine offset its acquisition cost by reducing medical service costs and demonstrated better drug treatment patterns than risperidone. |
2002-04-24 |
2023-08-12 |
Not clear |
| E Lindström, T Lewander, U Malm, U F Malt, H Lublin, U G Ahlfor. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nordic journal of psychiatry. vol 55 Suppl 44. 2002-04-04. PMID:11860666. |
the patient sample consisted of 63 patients with schizophrenia under maintenance treatment with risperidone, clozapine or classical antipsychotics. |
2002-04-04 |
2023-08-12 |
Not clear |